MedTrace Logo

The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation

NCT04382248 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2022-02-17

No results posted yet for this study

Summary

The purpose of this study is to examine the feasibility and acceptability of a mobile app to improve self-management skills and medication adherence in kidney transplantation, to assess the clinical benefit of mobile app in combination with tailored coaching using text messaging to enhance patient activation, self-management and medication adherence and to determine whether immunological biomarkers such as cell-free DNA and donor specific antibodies are associated with self-management and medication adherence.

Conditions

  • Medication Compliance

Interventions

OTHER

Smartphone App

An app for monitoring medications, blood pressure, exercise, healthy eating

BEHAVIORAL

Tailored education

in-person coaching

Sponsors & Collaborators

Principal Investigators

  • Eileen Chambers, MD · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-15
Primary Completion
2021-08-31
Completion
2021-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04382248 on ClinicalTrials.gov